拉夏貝爾(06116.HK)擬將回購A股方案實施期限延長6個月
格隆匯3月22日丨拉夏貝爾(06116.HK)公佈,第三屆董事會第四十次會議及第三屆監事會第二十三次會議於2020年3月20日舉行,於會上董事會及監事會審議並通過(其中包括)《關於回購A股股份實施期限延期的議案》。 根據《中華人民共和國公司法》、《關於支持上市公司回購股份的意見》等相關要求,公司擬將回購A股股份方案實施期限延長6個月,即將公司回購A股股份實施期限截止日期調整為2020年9月21日,並相應調整後續回購的資金總額。
建議A股購回授權延期須獲股東於公司臨時股東大會上以通過特別決議案的形式以及H股持有人及A股持有人分別於H股類別股東會及A股類別股東會上通過特別決議案批准。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.